![](/jdrfimpactreport2020/static/b11c9777d789fab38f5f8d241d529f1d/ec8cb/accelerating-research-hero.jpg)
Thanks to the support of our generous donors, JDRF is the leading charitable funder of type 1 diabetes (T1D) research in Canada. We also work jointly with our global affiliates to support projects around the world.
The pandemic could have impacted the pace of change but, thanks to your commitment, and the dedication of our researchers, we were still able to accelerate this crucial work.
JDRF Canada anticipates that funds to T1D research in 2021 will reach pre-pandemic levels. We also intend to substantially increase the amount of funding to T1D research per year in 2022 and beyond and aim to at least double our 2019 research funding annually by 2023. With this funding we will continue to support high-impact preclinical and clinical T1D research through conventional grants that help us advance our 4-pillared global research strategy, expand the portfolio of grants funded in partnership with CIHR and other funding agencies, and also launch a selection of special initiatives, including a JDRF Centre of Excellence at UBC focused on T1D cure research (launch date late 2021).
New Grants - 8
Clinical Trials - 12
Training Awards - 11
All Grants - 38
New Grants - 3
Clinical Trials - 10
Training Awards - 11
All Grants - 27